Advanced Therapies

Philadelphia, United States Founded: 1998 • Age: 28 yrs Acquired By Altaris
Biopharmaceutical products are manufactured on a contract basis.
Request Access

About Advanced Therapies

Advanced Therapies is a company based in Philadelphia (United States) founded in 1998 was acquired by Altaris in December 2024.. Advanced Therapies operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.

  • Headquarter Philadelphia, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Advanced Therapies, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Altaris

    (Dec 24, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Advanced Therapies
Headcount 500-1000
Employee Profiles 36
Employee Profiles
People
Andreas C. Solomos
Director
People
Don Schmidt
Assiciate Director Molecular Biology
People
Stephanie Angel
Associate Scientist/ Study Director - Electron Microscopy/ Virology
People
Adrienne Hayes
Associate Director Of Procurement

Unlock access to complete

Funding Insights of Advanced Therapies

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Advanced Therapies

Advanced Therapies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Altaris. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
PE firm invests in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Advanced Therapies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Advanced Therapies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Advanced Therapies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Advanced Therapies

Advanced Therapies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of protein formulation, process & cell line development, and cGMP services
domain founded_year HQ Location
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
domain founded_year HQ Location
Integrated biologics development and manufacturing are provided as a CDMO.
domain founded_year HQ Location
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
domain founded_year HQ Location
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
domain founded_year HQ Location
Precision fermentation services for biopharma and food are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Advanced Therapies

Frequently Asked Questions about Advanced Therapies

When was Advanced Therapies founded?

Advanced Therapies was founded in 1998.

Where is Advanced Therapies located?

Advanced Therapies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Who is the current CEO of Advanced Therapies?

Edward Hu is the current CEO of Advanced Therapies.

What does Advanced Therapies do?

Advanced Therapies was established in 1998 as a contract manufacturer in the biopharmaceutical sector. Operations are based in Philadelphia, United States, where services focused on producing biopharmaceutical products are provided to clients. Expertise in manufacturing processes for advanced therapies is utilized to support various biopharma needs, including formulation and production under regulatory standards. The company is led by CEO Edward Hu.

Who are the top competitors of Advanced Therapies?

Advanced Therapies's top competitors include KBI Biopharma, Aldevron and Ovagen.

Who are Advanced Therapies's investors?

Advanced Therapies has 1 investor. Key investors include Altaris.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available